Large Language Model - Enhanced Decision Tree Framework for Identifying Multiple Sclerosis Diagnoses from Clinical Documentation
Venkatesh, S.; DelSignore, M.; Wu, X.; Morris, M.; Kerr, W. T.; Visweswaran, S.; Wang, Y.; Xia, Z.
Show abstract
Background. Early diagnosis and intervention are crucial in multiple sclerosis (MS), yet diagnostic delays are common. Large language models (LLMs) such as generative pre-trained transformers (GPTs) may help streamline diagnostic workflows by extracting MS diagnostic signals from clinical notes. Objective. To derive MS diagnosis status from the first neurology note using a computable algorithm based on the 2017 McDonald criteria and applying GPT-4 for node-level reasoning within a structured decision framework. Methods. We analyzed first neurology notes from 125 randomly selected patients (including those with MS, related disorders, and controls) enrolled in a clinic cohort between 2017 and 2023. We included the clinical history and diagnostic testing sections but redacted the assessment and plan. We converted the 2017 McDonald criteria into a decision tree and provided expert-curated clinical knowledge to guide GPT-4 reasoning at each decision node. GPT-4 generated binary decisions at each node to traverse the tree and classified MS diagnoses at terminal nodes. We evaluated performance against neurologist-assessed diagnoses and characterized hallucinations (non-factual, incongruent, irrelevant, over-reliant, and logical reasoning errors). Results. In this study cohort (mean age 40{+/-}13 years; 81% women) representative of the clinic population, GPT-4 performed well in predicting MS diagnosis (84% accuracy, 79% precision, 74% recall, 91% specificity) using first neurology notes. Hallucinations occurred in 32 cases (26%), most commonly incoherence (75%) and overreliance (47%). Conclusion. A structured, LLM-guided decision framework can flag MS diagnoses from early clinical documentation. Large-scale studies are needed to mitigate hallucinations, validate this approach, and test implementation in clinical settings.
Matching journals
The top 4 journals account for 50% of the predicted probability mass.
Similar papers in this journal
Similar papers in this journal
- Post-COVID sequelae in people with multiple sclerosis and related disorders: a multicenter cross-sectional study 94%
- Choroid plexus volume predicts expansion of chronic lesions and brain atrophy 92%
- Hybrid and vaccine-induced immunity against SARS-CoV-2 in MS patients on different disease-modifying therapies 92%
Similar papers in this journal
- The relationship between ethnicity and Multiple Sclerosis characteristics in the United Kingdom: a UK MS Register study 94%
- Frequency and Potential Risk Factors Associated with the Development of Asymptomatic T2 Hyperintense Cervical Spine Lesions on MRI in Patients with Relapsing-Remitting Multiple Sclerosis 93%
- Multiple Sclerosis Cognitive Scale (MSCS): A Brief Psychometrically-Robust Metric of Patient-Reported Cognitive Difficulty 93%
Similar papers in this journal
- Current status and future opportunities in modeling Multiple Sclerosis clinical characteristics 94%
- The Canadian Collaborative Project on Genetic Susceptibility to Multiple Sclerosis cohort population structure and disease etiology 92%
- Alpha-Linolenic Acid Associations with Disability and Brain Volume in Multiple Sclerosis: A Brief Replication Report 91%
Similar papers in this journal
- COVID-19 is associated with multiple sclerosis exacerbations that are prevented by disease modifying therapies 93%
- The ocrelizumab phase II extension trial suggests the potential to improve the risk:benefit balance in multiple sclerosis 92%
- Neural Correlates of Remotely versus In-person Administered Symbol Digit Modalities Test in Multiple Sclerosis 91%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.